292 related articles for article (PubMed ID: 25452431)
1. α-Synuclein modifies mutant huntingtin aggregation and neurotoxicity in Drosophila.
Poças GM; Branco-Santos J; Herrera F; Outeiro TF; Domingos PM
Hum Mol Genet; 2015 Apr; 24(7):1898-907. PubMed ID: 25452431
[TBL] [Abstract][Full Text] [Related]
2. α-Synuclein modifies huntingtin aggregation in living cells.
Herrera F; Outeiro TF
FEBS Lett; 2012 Jan; 586(1):7-12. PubMed ID: 22119730
[TBL] [Abstract][Full Text] [Related]
3. α-Synuclein accumulates in huntingtin inclusions but forms independent filaments and its deficiency attenuates early phenotype in a mouse model of Huntington's disease.
Tomás-Zapico C; Díez-Zaera M; Ferrer I; Gómez-Ramos P; Morán MA; Miras-Portugal MT; Díaz-Hernández M; Lucas JJ
Hum Mol Genet; 2012 Feb; 21(3):495-510. PubMed ID: 22045698
[TBL] [Abstract][Full Text] [Related]
4. Nmnat restores neuronal integrity by neutralizing mutant Huntingtin aggregate-induced progressive toxicity.
Zhu Y; Li C; Tao X; Brazill JM; Park J; Diaz-Perez Z; Zhai RG
Proc Natl Acad Sci U S A; 2019 Sep; 116(38):19165-19175. PubMed ID: 31484760
[TBL] [Abstract][Full Text] [Related]
5. Uncoupling neuronal death and dysfunction in Drosophila models of neurodegenerative disease.
Chouhan AK; Guo C; Hsieh YC; Ye H; Senturk M; Zuo Z; Li Y; Chatterjee S; Botas J; Jackson GR; Bellen HJ; Shulman JM
Acta Neuropathol Commun; 2016 Jun; 4(1):62. PubMed ID: 27338814
[TBL] [Abstract][Full Text] [Related]
6. Co-occurrence of mixed proteinopathies in late-stage Huntington's disease.
St-Amour I; Turgeon A; Goupil C; Planel E; Hébert SS
Acta Neuropathol; 2018 Feb; 135(2):249-265. PubMed ID: 29134321
[TBL] [Abstract][Full Text] [Related]
7. α-Synuclein levels modulate Huntington's disease in mice.
Corrochano S; Renna M; Carter S; Chrobot N; Kent R; Stewart M; Cooper J; Brown SD; Rubinsztein DC; Acevedo-Arozena A
Hum Mol Genet; 2012 Feb; 21(3):485-94. PubMed ID: 22010050
[TBL] [Abstract][Full Text] [Related]
8. Synphilin suppresses α-synuclein neurotoxicity in a Parkinson's disease Drosophila model.
Hernández-Vargas R; Fonseca-Ornelas L; López-González I; Riesgo-Escovar J; Zurita M; Reynaud E
Genesis; 2011 May; 49(5):392-402. PubMed ID: 21584925
[TBL] [Abstract][Full Text] [Related]
9. CEP-1347 reduces mutant huntingtin-associated neurotoxicity and restores BDNF levels in R6/2 mice.
Apostol BL; Simmons DA; Zuccato C; Illes K; Pallos J; Casale M; Conforti P; Ramos C; Roarke M; Kathuria S; Cattaneo E; Marsh JL; Thompson LM
Mol Cell Neurosci; 2008 Sep; 39(1):8-20. PubMed ID: 18602275
[TBL] [Abstract][Full Text] [Related]
10. Fasudil attenuates aggregation of α-synuclein in models of Parkinson's disease.
Tatenhorst L; Eckermann K; Dambeck V; Fonseca-Ornelas L; Walle H; Lopes da Fonseca T; Koch JC; Becker S; Tönges L; Bähr M; Outeiro TF; Zweckstetter M; Lingor P
Acta Neuropathol Commun; 2016 Apr; 4():39. PubMed ID: 27101974
[TBL] [Abstract][Full Text] [Related]
11. Differential inhibition of α-synuclein oligomeric and fibrillar assembly in parkinson's disease model by cinnamon extract.
Shaltiel-Karyo R; Davidi D; Frenkel-Pinter M; Ovadia M; Segal D; Gazit E
Biochim Biophys Acta; 2012 Oct; 1820(10):1628-35. PubMed ID: 22575665
[TBL] [Abstract][Full Text] [Related]
12. Degradation of misfolded proteins in neurodegenerative diseases: therapeutic targets and strategies.
Ciechanover A; Kwon YT
Exp Mol Med; 2015 Mar; 47(3):e147. PubMed ID: 25766616
[TBL] [Abstract][Full Text] [Related]
13. Nortriptyline inhibits aggregation and neurotoxicity of alpha-synuclein by enhancing reconfiguration of the monomeric form.
Collier TJ; Srivastava KR; Justman C; Grammatopoulous T; Hutter-Paier B; Prokesch M; Havas D; Rochet JC; Liu F; Jock K; de Oliveira P; Stirtz GL; Dettmer U; Sortwell CE; Feany MB; Lansbury P; Lapidus L; Paumier KL
Neurobiol Dis; 2017 Oct; 106():191-204. PubMed ID: 28711409
[TBL] [Abstract][Full Text] [Related]
14. Glycation potentiates neurodegeneration in models of Huntington's disease.
Vicente Miranda H; Gomes MA; Branco-Santos J; Breda C; Lázaro DF; Lopes LV; Herrera F; Giorgini F; Outeiro TF
Sci Rep; 2016 Nov; 6():36798. PubMed ID: 27857176
[TBL] [Abstract][Full Text] [Related]
15. Green tea (-)-epigallocatechin-gallate modulates early events in huntingtin misfolding and reduces toxicity in Huntington's disease models.
Ehrnhoefer DE; Duennwald M; Markovic P; Wacker JL; Engemann S; Roark M; Legleiter J; Marsh JL; Thompson LM; Lindquist S; Muchowski PJ; Wanker EE
Hum Mol Genet; 2006 Sep; 15(18):2743-51. PubMed ID: 16893904
[TBL] [Abstract][Full Text] [Related]
16. The C-terminal α-helices of mammalian Hsc70 play a critical role in the stabilization of α-synuclein binding and inhibition of aggregation.
Chaari A; Eliezer D; Ladjimi M
Int J Biol Macromol; 2016 Feb; 83():433-41. PubMed ID: 26601760
[TBL] [Abstract][Full Text] [Related]
17. Interactions between Tau and α-synuclein augment neurotoxicity in a Drosophila model of Parkinson's disease.
Roy B; Jackson GR
Hum Mol Genet; 2014 Jun; 23(11):3008-23. PubMed ID: 24430504
[TBL] [Abstract][Full Text] [Related]
18. Alpha-synuclein overexpression promotes aggregation of mutant huntingtin.
Furlong RA; Narain Y; Rankin J; Wyttenbach A; Rubinsztein DC
Biochem J; 2000 Mar; 346 Pt 3(Pt 3):577-81. PubMed ID: 10698681
[TBL] [Abstract][Full Text] [Related]
19. Rapamycin and mTOR-independent autophagy inducers ameliorate toxicity of polyglutamine-expanded huntingtin and related proteinopathies.
Sarkar S; Ravikumar B; Floto RA; Rubinsztein DC
Cell Death Differ; 2009 Jan; 16(1):46-56. PubMed ID: 18636076
[TBL] [Abstract][Full Text] [Related]
20. Anti-oligomeric single chain variable domain antibody differentially affects huntingtin and alpha-synuclein aggregates.
Nannenga BL; Zameer A; Sierks MR
FEBS Lett; 2008 Feb; 582(4):517-22. PubMed ID: 18230361
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
